SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Veronisi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 12271232.
  • 2
    Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing radical mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med<. 2002; 347: 233241.
  • 3
    Rosen PP, Fracchia AA, Urban JA, et al. “Residual” mammary carcinoma following simulated partial mastectomy. Cancer. 1975; 35: 739747.
  • 4
    Vicini FA, Chen PY, Fraile M, et al. Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: preliminary results of a pilot trial. Int J Radiat Oncol Biol Phys. 1997; 38: 301310.
  • 5
    Vicini FA, Kini VR, Chen PY, et al. Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy. J Surg Oncol. 1999; 70: 3340.
  • 6
    Baglan KL, Martinez AA, Frazier RC, et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2001; 50: 10031011.
  • 7
    Vicini FA, Baglan KL, Kestin LL, et al. The accelerated treatment of breast cancer. J Clin Oncol. 2001; 19: 19932001.
  • 8
    Vicini FA, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003; 95: 12051210.
  • 9
    Chen P, Vicini F, Kestin L, et al. Long-term cosmetic results and toxicity with accelerated partial breast irradiation (APBI) utilizing interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2003; 57: S309S310.
  • 10
    Benitez PR, Chen PY, Vicini FA, et al. Partial breast irradiation in breast conserving therapy by way of interstitial brachytherapy. Am J Surg. 2004; 188: 355364.
  • 11
    King TA, Bolton JS, Kuske, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is, 1, 2) breast cancer. Am J Surg. 2000; 180: 229304.
  • 12
    Arthur D, Koo D, Zwicker RD. Partial breast brachytherapy following lumpectomy: a low dose rate and high dose rate experience. Int J Radiat Oncol Biol Phys. 2003; 56: 681689.
  • 13
    Wazer DE, Berle L, Graham R, et al. Preliminary results of a Phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002; 53: 889897.
  • 14
    Polgar C, Major T, Fodor J, et al. High-dose rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys. 2004; 60: 11731181.
  • 15
    Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997; 337: 949955.
  • 16
    Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997; 337: 956962.
  • 17
    Vicini FA, Kestin LL, Edmundson GK, et al. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys. 1999; 45: 803810.
  • 18
    Kestin LL, Jaffray DA, Edmundson GK, et al. Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys. 2000; 46: 3543.
  • 19
    Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31: 13411346.
  • 20
    Trotti, A, Byhardt R, Stetz J, et al. Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatments: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 2000: 47: 1347.
  • 21
    Rose MA, Olivotto IA, Cady B, et al. Conservative surgery and radiation therapy for early stage breast cancer: long-term cosmetic results. Breast Cancer. 1989; 124: 153157.
  • 22
    Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a Phase I–II study and initial findings of a randomized Phase III trial. J Surg Oncol. 2002; 80: 121128.
  • 23
    Olivotto IA, Weir LM, Kim-Sing C, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol. 1996; 41: 713.
  • 24
    Johansen J, Overgaard J, Rose C, et al. Cosmetic outcome and breast morbidity in breast-conserving treatment: results from the Danish DBCG-82M national randomized trial in breast cancer. Acta Oncol. 2002; 41: 369380.
  • 25
    Amichetti M, Busana L, Caffo O. Long-term cosmetic outcome and toxicity in patients with quadrantectomy and radiation therapy for early-stage breast cancer. Oncology. 1995; 52: 177181.
  • 26
    Al-Ghazal SK, Fallowfield L, Blamey RW. Does outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur J Surg Oncol. 1999; 25: 571573.
  • 27
    Meric F, Buchholz TA, Mirza NQ, et al. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol. 2002; 9: 543549.
  • 28
    Deutsch M, Flickinger JC. Patient characteristics and treatment factors affecting cosmesis following lumpectomy and breast irradiation. Am J Clin Oncol. 2003; 26; 4: 350–353.
  • 29
    Taylor ME, Perez CA, Halverson KJ, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 1995; 31: 753764.
  • 30
    Wazer DE, DiPetrillo T, Schmidt-Ullrich R, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast cancer. J Clin Oncol. 1992; 10: 356363.
  • 31
    Delouche G, Bachelot F, Premont M, et al. Conservation treatment of early breast cancer: long-term results and complications. Int J Radiat Oncol Biol Phys. 1987; 13: 2934.
  • 32
    Harris J, Levene MB, Svensson G, et al. Analysis of cosmetic results following primary radiation therapy for Stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1979; 5: 257261.
  • 33
    Perquin B, Huart J, Raynal M, et al. Conservative treatment for breast cancer: long term results (15 years). Radiother Oncol. 1991; 20: 1623.
  • 34
    Abner AL, Recht A, Vicini FA, et al. Cosmetic results after surgery, chemotherapy, and radiation therapy for early stage breast cancer. Int J Radiat Oncol Biol Phys. 1991; 21: 331338.
  • 35
    Markiewicz DA, Schultz DJ, Haas JA, et al. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy. Int J Radiat Oncol Biol Phys. 1996; 35: 661668.
  • 36
    Shah NM, Tenenholz T, Arthur D, et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation. Cancer. 2004; 101: 727734.
  • 37
    Hoeller U, Tribius S, Kuhlmey A, et al. Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA score. Int J Radiat Oncol Biol Phys. 2004; 55: 10131018.
  • 38
    Hoeller U, Kuhlmey A, Bajrovic A, et al. Cosmesis from the patient's and the doctor's view. Int J Radiat Oncol Biol Phys. 2003; 57: 345354.
  • 39
    Borgor JH, Kemperman H, Smitt HS, et al. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys. 1994; 30: 10731081.
  • 40
    Edmundson GK, Vicini FA, Chen PY, et al. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 2002; 52: 11321139.
  • 41
    Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003; 55: 289293.
  • 42
    Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2003; 55: 392406.
  • 43
    Vicini FA, Remouchamps V, Wallace M, et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003; 57: 12471253.
  • 44
    Formenti SC, Rosenstein B, Skinner KA, et al. T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients-pilot feasibility study. Radiology. 2002; 222: 171178.
  • 45
    Formenti SC, Truong MT, Goldberg JD, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2004; 60: 493504.
  • 46
    Radiation Therapy Oncology Group. RTOG 0413 broadcast, NSAPB B-39/RTOG 0413: “a randomized Phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with Stage 0, I or II breast cancer,” activated March 21, 2005. Available from URL: http://www.rtog.org/members/protocols/0413/0413broadcast.html [accessed April 5, 2005].